Jw Pharmaceutical
Clinical trials sponsored by Jw Pharmaceutical, explained in plain language.
-
New cholesterol drug livalozet tested in 1,500 patients
Disease control CompletedThis study looked at how well the drug Livalozet lowers bad cholesterol in people with high cholesterol, comparing those who also have diabetes to those who do not. Over 1,500 adults took part for 24 weeks. The main goal was to measure the drop in LDL cholesterol levels.
Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New diabetes combo pill shows promise in phase 3 trial
Disease control CompletedThis study tested whether adding the drug JW0201 to two other diabetes medications helps lower blood sugar in people with type 2 diabetes. 196 adults whose blood sugar was not well controlled on their current treatment took part. The main goal was to see if JW0201 reduced HbA1c l…
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New combo pill aims to tame stubborn diabetes
Disease control CompletedThis study tested whether adding JW0201 to two standard diabetes medications helps lower blood sugar more effectively in people with type 2 diabetes. About 200 adults whose blood sugar was not well controlled on their current drugs took either JW0201 or a placebo for 24 weeks. Th…
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 03:48 UTC
-
New gout drug epaminurad takes on febuxostat in major trial
Disease control CompletedThis phase 3 trial tested a new gout drug, epaminurad, against the standard treatment febuxostat in 612 adults with gout. The goal was to see which drug better lowers uric acid levels below 6 mg/dL. Participants took one of the two medications for several months, and researchers …
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New combo pill for high cholesterol shows promise in Late-Stage trial
Disease control CompletedThis phase 3 trial tested whether combining two drugs, JW0108 and C2407, can safely lower LDL (bad) cholesterol in people with dyslipidemia. 145 adults took part. The main goal was to see how much LDL cholesterol dropped from the start of the study. The trial is now complete.
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New combo pill cuts bad cholesterol in thousands
Disease control CompletedThis study looked at adults with high cholesterol who switched from a single statin drug to a combination pill containing pitavastatin and ezetimibe. Over 6,900 participants were followed for 24 weeks to see how much their LDL (bad) cholesterol dropped. The goal was to see if the…
Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Healthy volunteers test new drug combo for safety
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called epaminurad, alone and with naproxen, in 57 healthy adults aged 19 to 50. Researchers measured how the drugs move through the body and checked for side effects. The goal was to gather safety data, not to treat any disea…
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC
-
Healthy volunteers test new drug epaminurad in Early-Stage safety study
Knowledge-focused CompletedThis early-stage study looked at how safe a new drug called epaminurad is and how it moves through the body. It involved 34 healthy adults who took a single dose of the drug while fasting. The goal was to measure drug levels in the blood, not to treat any disease.
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 26, 2026 03:52 UTC
-
Healthy men test new combo pill for cholesterol and blood pressure
Knowledge-focused CompletedThis study looked at how a single pill that combines two drugs (pitavastatin for cholesterol and valsartan for blood pressure) works compared to taking the two drugs separately. It involved 52 healthy men aged 20-55. The goal was simply to measure drug levels in the body, not to …
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 26, 2026 03:47 UTC
-
Healthy volunteers test drug combo in early safety study
Knowledge-focused CompletedThis early-stage study looked at how two drugs, epaminurad and C2406, affect each other in the body. 18 healthy adults took the drugs separately and together to check safety and drug levels. The goal was to gather information, not to treat any disease.
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 26, 2026 03:46 UTC
-
Healthy men help scientists track how a drug moves through the body
Knowledge-focused CompletedThis study looked at how the drug epaminurad is processed and removed from the body. Eight healthy men took a single dose, and researchers measured the drug and its breakdown products in blood, urine, and stool. The goal was to understand the drug's journey, not to treat any dise…
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Healthy volunteers test new drug combinations in early safety trial
Knowledge-focused CompletedThis study looked at how safe three drugs (JW0104, C2402, and JW0105) are and how the body processes them when taken together or alone. It involved 60 healthy volunteers who took a single dose under fasting conditions. The goal was to gather information, not to treat any disease.
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC